{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-23-000086","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2023-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.270373+00:00","generated_at":"2026-06-14T09:33:03.444013+00:00","sec_items":["2.01","2.03","1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Viemed completes $28M acquisition of Home Medical Products; guides Q2 rev $42.5M-$43.5M","bullets":["Acquired HMP for ~$28M cash; funded by $15M cash on hand and $13M from existing credit facilities.","HMP serves ~45,000 active patients with ~180 employees in Tennessee, Alabama, and Mississippi.","Viemed expects Q2 2023 core net revenue of $42.5M-$43.5M, including one month of HMP revenue.","Acquisition closed June 1, 2023; expands product, payor, and geographic diversity."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-23-000086","json":"https://secwatch.observer/filing/0001729149-23-000086.json","markdown":"https://secwatch.observer/filing/0001729149-23-000086.md","text":"https://secwatch.observer/filing/0001729149-23-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/0001729149-23-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/vmd-20230601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T09:33:03.444013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"684a2335dc4483f3b52a41e4982213e2210ca094","claim":"VIEMED HEALTHCARE, INC. completed an acquisition involving Home Medical Products, Inc. for approximately $28 million in cash (closed 2023-06-01).","evidence_excerpt":"HMP, Kevin Atkins and David Steele (collectively, the “Stockholders”). Viemed acquired from the Stockholders 100% of the equity ownership of HMP in exchange for approximately $28 million in cash, subject to customary post-closing net working capital and other adjustments. Approximately $15 million of the purchase consideration was funded by cash on hand, $8","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729149/000172914923000086/0001729149-23-000086-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Home Medical Products, Inc."},{"label":"Consideration","value":"approximately $28 million in cash"},{"label":"Closing","value":"2023-06-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}